The Shareholders Foundation announces that an investigation on behalf of current long-term stockholders of shares of PharMerica Corporation (NYSE:PMC) was launched concerning whether certain PharMerica officers and directors possibly breached their fiduciary duties in connection with certain statements.
Investors who are current long-term stockholder of shares of PharMerica Corporation (NYSE:PMC) have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain PharMerica officers and directors breached their fiduciary duties and caused damage to the company and its shareholders by, among other things, failing to implement adequate internal controls.
PharMerica Corporation reported that its annual Total Revenue declined from over $2.08 billion in 2011 to over $1.83 billion in 2012 and that its respective Net Income declined from $23.40 million to $2.90 million.
On August 9, 2013 the Department of Justice announced that it had filed a suit against PharMerica Corporation for allegedly violating the False Claims Act and the Controlled Substances Act by dispensing controlled substances without valid prescriptions and causing claims for illegally dispensed drugs to be submitted for reimbursement under the Medicare program.
Shares of PharMerica Corporation (NYSE:PMC) declined from $15.27 per share in August 5, 2013, to $13.30 per share on August 15, 2013.
Those who purchased shares of PharMerica Corporation have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Trevor Allen
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com